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ABSTRACT
Objective: To evaluate the health-related quality of life of patients submitted to resection of the pulmonary parenchyma
due to neoplasia. Methods: The Medical Outcomes Study 36-item Short-Form Health Survey was used to evaluate
patients in the preoperative period and on postoperative days 30, 90 and 180. We used the GEE statistical model, in
which the dependent variable (quality of life) changes for each patient over the course of the evaluation. Independent
variables were gender, age, educational level, type of surgery, radiotherapy, chemotherapy, forced vital capacity and 6-
minute walk test. The level of significance adopted was 5%. Results: The final study sample comprised 36 patients, 20
of whom were men. Of those 36 patients, 17 were submitted to lobectomy, 10 to pneumonectomy, 6 to segmentectomy,
and 3 to bilobectomy. Chemotherapy was used in 15 patients, radiotherapy in 2, and a combination of radiotherapy and
chemotherapy in 2. Improved quality of life was seen in the following domains: social (on postoperative day 90);
physical/functional (some patients presenting better forced vital capacity and 6-minute walk test performance); and
physical (in patients undergoing smaller resections). Lowered quality of life was seen in the following domains: social (for
female patients); physical/social (resulting from radiotherapy, chemotherapy or both); and physical/functional (by
postoperative day 30). Conclusions: It is important that studies evaluating the various determinants of quality of life,
as well as the impact that cancer treatment modalities have on such variables, be conducted. The knowledge provided by
such studies can contribute to improving the quality of life of patients undergoing pulmonary resection due to neoplasia.
Keywords: Lung neoplasms/surgery; Pneumonectomy; Quality of life; Questionnaires
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INTRODUCTION
Oncological pathologies constitute a serious
public health problem, chief among which are lung
neoplasia and metastatic lung cancer. In 2001, lung
cancer was responsible for more than one million
deaths worldwide, with a global increase of 0.5%
per year, which is principally related to an increase
among women. Lung cancer is highly lethal,
incidence and mortality rates generally being nearly
equal.(1-3)
An analysis of mortality due to lung cancer in
Brazil demonstrated that, between 1979 and 2000,
lung cancer mortality rates rose from 7.73/100,000
to 12.13/100,000 among men (a relative percentage
variation of +57%, whereas a rise from 2.33/100,000
to 5.33/100,000 (+134%) was seen among women.
The numbers of lung cancer deaths predicted for
2003 were 11,315 for men and 4,915 for women.(4)
Surgery involving resection of the lung
parenchyma has been cited as the only method of
curing lung cancer and other metastatic tumors in
the lung.(5) Unfortunately, only 20% of the lung
carcinomas may be submitted to surgery due to the
fact that most of them present advanced anatomical
staging in the assessment, or associated
comorbidities that contraindicate surgery.(6)
There is an increased involvement of health
professionals in the treatment of patients with this
pathology, all aiming to offer the best treatment
possible. Protocols that determine the impact of the
surgical procedure on functional status and daily
activities are fundamental instruments that must be
routinely implemented in order to improve quality
of life (QoL).
The concept of QoL is a subjective and one that
presupposes an ideal individualized level of values,
capacities, satisfaction and well-being. Generic and
specific standardized questionnaires that produce
scores for the various aspects involved are used in
order to evaluate QoL.(7-9)
Generic questionnaires have been developed to
reflect the impact of a disease on the life of patients
in a wide variety of populations.(9) One of the most
commonly cited in the literature is The Medical
Outcomes Study 36-item Short-Form Health Survey
(SF-36), which has been one of the principal
instruments validated for use in Portuguese. Since
it is easily applied and easily understood by the
patient, the SF-36 is currently used in clinical
research and epidemiological studies.(10)
The choice of this instrument was based on the
interest in having access to a generic health evaluation
questionnaire, in Portuguese, that presents
measurement properties such as reproducibility,
validity and susceptibility to alterations.(9)
The objective of the present study is to analyze
the health-related QoL of patients submitted to
resection of the lung parenchyma due to neoplasia,
applying the SF-36 in the preoperative period and
again on postoperative days 30, 90 and 180.
METHOD
This was a prospective study, carried out between
October 2001 and December 2003, in which we
evaluated the performance and the QoL of adult
patients, of both genders, submitted to lung
resection due to a malignant neoplasm. In the
preoperative period, the evaluation was carried out
in the thoracic surgery ward of the State University
at Campinas Hospital das Clínicas. Subsequently,
patients were monitored as outpatients and were
submitted to fol low-up assessments on
postoperative days 30, 90 and 180.
The study was approved by the ethics in research
committee of the institution, and all patients gave
written informed consent.
Patients who failed to complete the six-month
postoperative follow-up period, were diagnosed with
benign diseases or were submitted to a second lung
resection during the follow-up period, as well as
patients whose resections were not considered
curative, were excluded from the study.
The preoperative evaluation was carried out using
the perioperative respiratory therapy scale of surgical
risk,(11) which is used to assess the risk of postoperative
pulmonary complications. Data regarding
postoperative type of respiration, lung auscultation,
intercurrent lung diseases and respiratory therapy
procedures were obtained through review of medical
charts.
In the four phases of the evaluation, patients
were submitted to the following procedures:
spirometric tests to determine forced vital capacity
(FVC); (12-13) the 6-minute walk test (6MWT)(12); and
application of the SF-36.(9-10)
The SF-36 is a multidimensional questionnaire
(comprising 36 questions) that evaluates patient
perceptions of their own health status. Rather than
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being disease-specif ic, the questionnaire
demonstrates how involved the patient is with the
disease, and its application is related to health care
interventions conducted in the course of community
health programs or clinical research.(10,14-15)
The following are the domains investigated by
the questionnaire: physical (in which symptoms such
as pain, fatigue, nausea and medication effects are
assessed); functional (which addresses patient
mobility, daily activities and performance at work);
psychological (in which patient satisfaction with
their health status and with life in general, as well
as symptoms such as depression or anxiety, are
assessed); and social (dealing with family,
professional and social aspects).
These questions are based on the perception
that patients have of their health status in the
preceding four weeks. In order to obtain the results
in each of the components or dimensions, the score
obtained on each question is recorded and then
transformed into a scale ranging from zero (worst
score) to 100 (best score).(9)
All patients underwent respiratory therapy during
hospitalization and participated in the postoperative
pulmonary rehabilitation program for at least two
months.(16-17)
In order to study the influence of the variables
of interest on the QoL throughout the four phases
of collection, we performed an analysis using
generalized linear models and generalized estimation
equation (GEE) estimates. The level of statistical
significance adopted was 5%.(18-19)
RESULTS
A total of 36 patients participated in the study: 16
females (44.4%) and 20 males (55.6%). Patient ages
ranged from 18 to 78 years, and 4 patients (11%)
were under 40. Median age was 55.5 ± 13.4 years.
A total of 49 patients were excluded: 20 because
they failed to conclude the study; 13 because they
were diagnosed with benign diseases; 9 because
they were submitted to a second operation; and 7
because they were submitted to resections that were
not considered curative.
The anatomopathological test results revealed
26 primary lung tumors, 10 adenocarcinomas and
10 epidermoid carcinomas. In addition, 4 tumors
were classified as carcinoid, 1 as large-cell carcinoma
and 1 as adenoid cystic carcinoma. Another 8 lung
tumors were considered metastatic in origin. Of
those, 5 were classified as carcinoma (3 colon
carcinomas, 1 liver carcinoma and 1 undifferentiated
carcinoma), 2 as melanoma and 1 as soft tissue
sarcoma. Two patients were diagnosed with primary
chest wall tumor with invasion of the lung
parenchyma.
Segmentectomy was performed in 6 patients
(16.7%), lobectomy in 17 (47.2%), bilobectomy
in 3 (8.35) and pneumonectomy in 10 (27.8%).
In the immediate postoperative period, pulmonary
complications occurred in 3 patients. According to
the perioperative respiratory therapy surgical risk
scale, 1 of those patients had been at low risk, and
the other two had been at moderate risk.
There were 17 patients (47.2%) who received
neither radiotherapy nor chemotherapy, whereas
15 (41.7%) received chemotherapy alone, 2 (5.6%)
received radiotherapy alone, and 2 (5.6%) received
a combination of the two.
The results of the analysis using the generalized
linear models and the GEE were adjusted for each
domain of the SF-36 according to the independent
variables of interest (gender, age, educational level,
type of surgery, radiotherapy, chemotherapy, FVC
and distance walked on the 6MWT).
In the analysis of the functional capacity domain,
we observed statistically significant correlations
between some variables and QoL (Table 1). Greater
distance walked on the 6MWT and higher FVC both
correlated with improved QoL (p < 0.003 and p <
0.011, respectively). In patients who were submitted
to radiotherapy, chemotherapy or both, QoL was
lower (p < 0.004). An overall drop in QoL was also
seen by postoperative day 30.
TABLE 1
Analysis of the generalized estimation equations
for quality of life using the functional capacity
domain of the Medical Outcomes Study 36-item
Short-Form Health Survey
Variable   Estimate Standard    Z      p
    error     score
6-minute walk test 0.001 0.000 2.897 0.003
Forced vital capacity 0.005 0.002 2.541 0.011
Radiotherapy, -0.235 0.082 -2.849 0.004
chemotherapy or both
Postoperative day 30 -0.381 0.139 -2.742 0.006
SF-36: The Medical Outcomes Study 36-item Short-Form
Health Survey
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In the physical aspect domain, improved QoL
correlated significantly with better performance on
the 6MWT (p < 0.0002) and with more limited
resection of the lung parenchyma (p < 0.04), as
shown in Table 2.
Lower QoL was found to correlate with the use
of radiotherapy or chemotherapy (p < 0.024) and
with postoperative day 30 (p < 0.028).
In the general health status domain, we found
a statistically significant correlation between
improved QoL and the independent variable 6MWT
(p < 0.03) (Table 3).
When we analyzed the vitality domain, we
observed that the use of radiotherapy,
chemotherapy or both correlated with lower QoL
(p < 0.025) (Table 4).
In the analysis of the preoperative period and
the three phases of evaluation of the postoperative
period, patients presented improved QoL in the
social aspect domain from postoperative day 90
onward (p < 0.0005). Females presented lower QoL
than that observed for males (p < 0.010). Patients
submitted to radiotherapy, chemotherapy or both
also presented lower QoL (p < 0.06) (Table 5).
DISCUSSION
Among the four interviews, the second, which
occurred on postoperative day 30, was the most
difficult to carry out due to the general health
status of the patients, especially in terms of pain,
discomfort at the surgical incision site, tingling or
physical debilitation. From postoperative day 90
onward, patients showed signs of greater physical
independence, were more hopeful and were more
committed to continuing the treatment.
When gender was analyzed as an independent
variable using the GEE statistical model, females
presented lowed QoL in the social aspect domain
(p < 0.010). Other authors have found that
postoperative comorbidities are more common in
males, thereby contributing to lower QoL.(1,20) In
patients submitted to more limited resection of
the lung parenchyma, QoL in the physical aspect
domain was improved, and the difference was
statistically significant (p < 0.046). Few authors
have found QoL to be correlated with resection
TABLE 2
Analysis of the generalized estimation equations
for quality of life using the physical aspect domain
of the Medical Outcomes Study 36-item Short-
Form Health Survey
Variable                  Estimate Standard   Z       p
                                        error
6-minute walk test 0.001 0.000 3.708 0.0002
Segmentectomy/lobectomy 0.189 0.095 1.987 0.046
Radiotherapy, -0.172 0.077 -2.244 0.024
chemotherapy or both
Postoperative day 30 -0.335 0.153 -2.191 0.028
SF-36: The Medical Outcomes Study 36-item Short-Form
Health Survey
TABLE 3
Analysis of the generalized estimation equations
for quality of life using the general health status
domain of the Medical Outcomes Study 36-item
Short-Form Health Survey
Variable              Estimate    Standard    Z      p
                                         error
6-minute walk test     0.001         0.000    2.108  0.03
SF-36: The Medical Outcomes Study 36-item Short-Form
Health Survey
TABLE 4
Analysis of the generalized estimation equations
for quality of life using the vitality domain of the
Medical Outcomes Study 36-item Short-Form
Health Survey
Variable              Estimate Standard     Z         p
                                     error
Radiotherapy,  -0.302 0.135 -2.229 0.025
chemotherapy or both
SF-36: The Medical Outcomes Study 36-item Short-Form
Health Survey
TABLE 5
Analysis of the generalized estimation equations
for quality of life using the social aspect domain
of the Medical Outcomes Study 36-item Short-
Form Health Survey
Variable             Estimate  Standard     Z        p
                                     error
Postoperative day 90 0.322 0.091 3.506 0.0005
Females -0.258 0.100 -2.576 0.010
Radiotherapy, -0.292 0.107 -2.719 0.006
chemotherapy or both
SF-36: The Medical Outcomes Study 36-item Short-Form
Health Survey
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of the lung parenchyma. However, some do not
consider that the type of surgery is predictive of
lower QoL.(21) Studies in the literature have made
va luable  contr ibut ions  to es tab l i sh ing a
relationship between the type of surgery and
morbidity/mortality. According to some authors,
patients submitted to pneumonectomy presented
a higher risk of complication than did those
submitted to lobectomy.(22) Other authors have
cited mortality as a complication related to the
extent of the surgery.(1,23-24)
No improvement in QoL was observed as a result
of radiotherapy or chemotherapy. Actually, such
treatment was correlated with worsening in the
following domains: functional capacity (p < 0.004);
physical aspects (p < 0.024); vitality (p < 0.025);
and social aspects (p < 0.006).
In a study involving twelve patients with chest
cancer, no worsening of QoL or pulmonary
function was found to result from the use of
radiotherapy, chemotherapy or both.(25) With
regard to pulmonary function, median FVC
dropped from 98.5 ± 18.0% in the preoperative
period to 81.5 ± 23.3% on postoperative day 180.
When the statistical analysis was carried out using
the GEE statistical model, FVC was found to be
predictive of improved QoL in the functional
capacity domain (p < 0.011). However, other
authors have found that there was no correlation
between the SF-36 results and pulmonary
function.(21,26) In the 6MWT, the distance walked
in the preoperative period was 509 ± 99.5 m,
compared with 506 ± 95.1 m on postoperative
day 180. When the GEE statistical model was used,
we observed that the distance walked on the
6MWT was predictive of improved QoL in the
following domains: functional capacity (p <
0.0003); physical aspects (p < 0.0002); and
general health status (p < 0.03).
These results differ from those of another study
involving patients with lung cancer, in which a mean
of 414 ± 107 meters was obtained on postoperative
day 180. However, in that study, this variable was
not found to be predictive of QoL.(21) The results
obtained on the 6MWT in the present study seem
to differ from those found in the aforementioned
study since our patients have maintained better
conditions of nutrition, culture, transportation and
medication.
According to some authors, patients submitted
to surgical therapy of bronchogenic carcinoma
present an immediate postoperative drop in QoL,
which is only restored to preoperative status at three
to six months after the surgery.(27) The surgical
procedure and the perception of QoL have a
negative impact that can be influenced by several
physical and emotional factors.
To the detriment of QoL, the impairment of daily
life activities (such as domestic chores), hair loss
and weight loss run parallel to the disease stages.
There is a significant correlation between these
aspects and patient perception of QoL. Further
studies are needed in order to clarify prognostic
determinants, biological factors, immunologic
factors, tumor markers, laboratory tests for prognoses
and general aspects of QoL.(28)
After lung resection, patients may be affected
by pulmonary complications, such as atelectasis
and pneumonia, and might require prolonged
mechanical ventilation, in addition to the daily
activity limitations and the use of supplemental
oxygen. It has been suggested that the positive and
negative preoperative predictors be explained to
patients, and that they be fully informed of the
possibility of postoperative physical or respiratory
debilitation.(24)
Due to the functional worsening, it has been
suggested that patients with lung cancer formally
participate in rehabilitation programs, thereby
relieving the deleterious effects of the surgery,
of the disease and of the treatment proposed.(29)
High- and low-intensity exercises are resources
that can prevent or minimize physical inactivity,
fatigue and frailty, thereby contributing to
patient recovery.(30)
We conclude that patients submitted to lung
resection due to neoplasm present improved QoL in
the following domains: functional (patients presenting
higher FVC and better 6MWT performance); physical
aspects and general health status (patients presenting
better 6MWT performance); physical (in patients
undergoing more limited surgical resections) and
social (by postoperative day 90).
Lower QoL was seen in the following domains:
functional/physical (by postoperative day 30),
functional/physical/vitality/social (resulting form
radiotherapy, chemotherapy or both) and social (for
female patients).
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